Advertisement
Advertisement
U.S. markets close in 2 hours 46 minutes
Advertisement
Advertisement
Advertisement
Advertisement

China Resources Beer (Holdings) Company Limited (0291.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
62.500+1.550 (+2.54%)
At close: 04:08PM HKT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close60.950
Open60.950
Bid62.450 x 0
Ask62.500 x 0
Day's Range60.100 - 62.900
52 Week Range53.350 - 78.600
Volume7,025,152
Avg. Volume7,351,751
Market Cap202.75B
Beta (5Y Monthly)0.71
PE Ratio (TTM)139.82
EPS (TTM)0.447
Earnings DateAug 18, 2021
Forward Dividend & Yield0.47 (0.76%)
Ex-Dividend DateAug 31, 2021
1y Target Est76.10
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 0291.HK

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021

      Company announcement – No. 73 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021 Copenhagen, DK and Boston, MA, November 30, 2021 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders: T

    • GlobeNewswire

      Total number of shares and voting rights in Zealand Pharma at November 30, 2021

      Company announcement – No. 72 / 2021 Total number of shares and voting rights in Zealand Pharma at November 30, 2021 Copenhagen, DK and Boston, MA, November 30, 2021 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the

    • GlobeNewswire

      Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2021

      Company announcement – No. 71 / 2021 Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2021 Copenhagen, DK and Boston, MA, November 29, 2021 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholder: Followi

    Advertisement
    Advertisement